Treatment of comorbidities of chronic daily headache

Sait Ashina, Richard B. Lipton, Marcelo E. Bigal

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The treatment of chronic daily headaches should focus not only on establishing an effective plan for pain therapy but also on addressing factors that may diminish progression from episodic headache toward chronic daily headache. These measures may translate into better treatment efficacy and satisfaction, as well as decrease the headache burden. Because episodic migraine progresses to chronic daily headache in some (not most) individuals, research will increasingly focus on identifying factors associated with progression, such as specific genetic and environmental risk factors, including comorbidities. Ultimately, the assessment of the migraine patient will include an evaluation of risk factors for progression. In addition to the symptom profile, evaluation will increasingly focus on comorbidities, ictal and interictal functional consequences of migraine, health-related quality of life, treatment needs, and treatment preferences. Estimation of the risk of progression will incorporate assessments of comorbidity, exposures, and eventually biomarkers. Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden.

Original languageEnglish (US)
Pages (from-to)36-43
Number of pages8
JournalCurrent Treatment Options in Neurology
Volume10
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Headache Disorders
Comorbidity
Migraine Disorders
Headache
Therapeutics
Pain
Symptom Assessment
Biomarkers
Stroke
Quality of Life
Research

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Treatment of comorbidities of chronic daily headache. / Ashina, Sait; Lipton, Richard B.; Bigal, Marcelo E.

In: Current Treatment Options in Neurology, Vol. 10, No. 1, 01.2008, p. 36-43.

Research output: Contribution to journalArticle

Ashina, Sait ; Lipton, Richard B. ; Bigal, Marcelo E. / Treatment of comorbidities of chronic daily headache. In: Current Treatment Options in Neurology. 2008 ; Vol. 10, No. 1. pp. 36-43.
@article{0bbfbb3e187b42b4961208b421c7f1f4,
title = "Treatment of comorbidities of chronic daily headache",
abstract = "The treatment of chronic daily headaches should focus not only on establishing an effective plan for pain therapy but also on addressing factors that may diminish progression from episodic headache toward chronic daily headache. These measures may translate into better treatment efficacy and satisfaction, as well as decrease the headache burden. Because episodic migraine progresses to chronic daily headache in some (not most) individuals, research will increasingly focus on identifying factors associated with progression, such as specific genetic and environmental risk factors, including comorbidities. Ultimately, the assessment of the migraine patient will include an evaluation of risk factors for progression. In addition to the symptom profile, evaluation will increasingly focus on comorbidities, ictal and interictal functional consequences of migraine, health-related quality of life, treatment needs, and treatment preferences. Estimation of the risk of progression will incorporate assessments of comorbidity, exposures, and eventually biomarkers. Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden.",
author = "Sait Ashina and Lipton, {Richard B.} and Bigal, {Marcelo E.}",
year = "2008",
month = "1",
doi = "10.1007/s11940-008-0005-1",
language = "English (US)",
volume = "10",
pages = "36--43",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Treatment of comorbidities of chronic daily headache

AU - Ashina, Sait

AU - Lipton, Richard B.

AU - Bigal, Marcelo E.

PY - 2008/1

Y1 - 2008/1

N2 - The treatment of chronic daily headaches should focus not only on establishing an effective plan for pain therapy but also on addressing factors that may diminish progression from episodic headache toward chronic daily headache. These measures may translate into better treatment efficacy and satisfaction, as well as decrease the headache burden. Because episodic migraine progresses to chronic daily headache in some (not most) individuals, research will increasingly focus on identifying factors associated with progression, such as specific genetic and environmental risk factors, including comorbidities. Ultimately, the assessment of the migraine patient will include an evaluation of risk factors for progression. In addition to the symptom profile, evaluation will increasingly focus on comorbidities, ictal and interictal functional consequences of migraine, health-related quality of life, treatment needs, and treatment preferences. Estimation of the risk of progression will incorporate assessments of comorbidity, exposures, and eventually biomarkers. Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden.

AB - The treatment of chronic daily headaches should focus not only on establishing an effective plan for pain therapy but also on addressing factors that may diminish progression from episodic headache toward chronic daily headache. These measures may translate into better treatment efficacy and satisfaction, as well as decrease the headache burden. Because episodic migraine progresses to chronic daily headache in some (not most) individuals, research will increasingly focus on identifying factors associated with progression, such as specific genetic and environmental risk factors, including comorbidities. Ultimately, the assessment of the migraine patient will include an evaluation of risk factors for progression. In addition to the symptom profile, evaluation will increasingly focus on comorbidities, ictal and interictal functional consequences of migraine, health-related quality of life, treatment needs, and treatment preferences. Estimation of the risk of progression will incorporate assessments of comorbidity, exposures, and eventually biomarkers. Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden.

UR - http://www.scopus.com/inward/record.url?scp=38749084119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749084119&partnerID=8YFLogxK

U2 - 10.1007/s11940-008-0005-1

DO - 10.1007/s11940-008-0005-1

M3 - Article

VL - 10

SP - 36

EP - 43

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 1

ER -